News & Events
DavosLife in the In-Cosmetics Asia, Bangkok
Find out our flyer & poster
Davos is sponsoring γ-tocotrienol for the treatment of prostate cancer, a pre-clinical research by Australian Prostate Cancer Research Institute
Prostate cancer is the most common type of cancer in developed countries. The research team have discovered a particular form of T3, called gamma-tocotrienol (γ-T3), can successfully kill off the prostate cancer CSCs.
Press Release: Tocotrienols shown to be effective in lowering fat levels in blood
Scientists from Singapore found that tocotrienols, which are members of the Vitamin E family, are effective in lowering the levels of triglyceride, a form of fat in the blood. High levels of triglyceride are closely linked to an increased risk of cardiovascular and metabolic diseases.
DavosLife is invited to present “Gamma-Tocotrienol: An active agent to target prostate cancer stem cell population”
DavosLife is invited to The 7th Japanese Society Tocotrienol Research to present “Gamma-Tocotrienol: An Active Agent To Target Prostate Cancer Stem Cell Population”
New ingredient for beverages good for our heart
Scientists have found that gamma and delta tocotrienols, derived naturally from palm oil, are potent in lowering triglyceride levels (-27%) in the blood after two months of tocotrienol supplementation. In addition, tocotrienol-treated subjects in the […]
Press release: Tocotrienols shown to inhibit skin pigment production
We conducted an in-house human clinical trial using a topical cream base containing 2% gamma-tocotrienol. After one month of dermal application, there was significant lightening of age spots.
Press release: Gamma-tocotrienol kills prostate cancer stem cells
Latest study reveals that gamma-tocotrienol is effective in targeting prostate cancer stem cells, offering a potential means to prevent cancer growth and disease relapse